Vimarsana
Biggest News Aggregation in the World

Page 6 - Transfer Hub News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transfer Hub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transfer Hub Today - Breaking & Trending Today

Global Citizen Announces Lineups For 2022 Global Citizen Festival In Accra & New York City On September 24 - Vimarsana News

Global Citizen Announces Lineups For 2022 Global Citizen Festival In Accra & New York City On September 24

Global Citizen Announces Lineups For 2022 Global Citizen Festival In Accra & New York City On September 24

GLOBAL CITIZEN FESTIVAL SET TO HOLD SEPTEMBER 24 IN ACCRA & NEW YORK CITY, LINEUPS UNVEILED - Vimarsana News

GLOBAL CITIZEN FESTIVAL SET TO HOLD SEPTEMBER 24 IN ACCRA & NEW YORK CITY, LINEUPS UNVEILED

MULTI-AWARD-WINNING NIGERIAN SINGER TEMS, USHER, SARKODIE, SZA, STORMZY, H.E.R., GYAKIE AND STONEBWOY TO PERFORM AT THE BLACK STAR SQUARE IN ACCRA Lagos,

Source: ynaija.com
New agreement could lead to first African-owned COVID-19 vaccine - Vimarsana News

New agreement could lead to first African-owned COVID-19 vaccine

Two biotech companies – Afrigen Biologics and the Univercells Group – are set to work together on a COVID vaccine.

New agreement paves way for development of first African-owned COVID-19 vaccine - Vimarsana News

New agreement paves way for development of first African-owned COVID-19 vaccine

One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two of the world’s leading biotech companies - Afrigen Biologics and the Univercells Group – was announced today. This agreement intends to pave the way for the development of the first-ever African-owned COVID-19 ...

Drug companies sidestepping the WHO's technology transfer hub in Africa - Vimarsana News

Drug companies sidestepping the WHO's technology transfer hub in Africa

Moderna has decided to continue making the vaccine itself, a sign that they are not looking to license third party manufacturers soon.